These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22258158)

  • 1. Deletion at chromosome 10p11.23-p12.1 defines characteristic phenotypes with marked midface retrusion.
    Okamoto N; Hayashi S; Masui A; Kosaki R; Oguri I; Hasegawa T; Imoto I; Makita Y; Hata A; Moriyama K; Inazawa J
    J Hum Genet; 2012 Mar; 57(3):191-6. PubMed ID: 22258158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microdeletion at chromosome 4q21 defines a new emerging syndrome with marked growth restriction, mental retardation and absent or severely delayed speech.
    Bonnet C; Andrieux J; Béri-Dexheimer M; Leheup B; Boute O; Manouvrier S; Delobel B; Copin H; Receveur A; Mathieu M; Thiriez G; Le Caignec C; David A; de Blois MC; Malan V; Philippe A; Cormier-Daire V; Colleaux L; Flori E; Dollfus H; Pelletier V; Thauvin-Robinet C; Masurel-Paulet A; Faivre L; Tardieu M; Bahi-Buisson N; Callier P; Mugneret F; Edery P; Jonveaux P; Sanlaville D
    J Med Genet; 2010 Jun; 47(6):377-84. PubMed ID: 20522426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3q27.3 microdeletional syndrome: a recognisable clinical entity associating dysmorphic features, marfanoid habitus, intellectual disability and psychosis with mood disorder.
    Thevenon J; Callier P; Poquet H; Bache I; Menten B; Malan V; Cavaliere ML; Girod JP; Thauvin-Robinet C; El Chehadeh S; Pinoit JM; Huet F; Verges B; Petit JM; Mosca-Boidron AL; Marle N; Mugneret F; Masurel-Paulet A; Novelli A; Tümer Z; Loeys B; Lyonnet S; Faivre L
    J Med Genet; 2014 Jan; 51(1):21-7. PubMed ID: 24133203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtelomeric chromosomal rearrangements detected in patients with idiopathic mental retardation and dysmorphic features.
    Caliskan MO; Karauzum SB; Mihci E; Tacoy S; Luleci G
    Genet Couns; 2005; 16(2):129-38. PubMed ID: 16080292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cytogenetic characterization of an interstitial deletion of chromosome 21 (21q22.13q22.3) in a patient with dysmorphic features, intellectual disability and severe generalized epilepsy.
    Valetto A; Orsini A; Bertini V; Toschi B; Bonuccelli A; Simi F; Sammartino I; Taddeucci G; Simi P; Saggese G
    Eur J Med Genet; 2012 May; 55(5):362-6. PubMed ID: 22548977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo microdeletions of chromosome 6q14.1-q14.3 and 6q12.1-q14.1 in two patients with intellectual disability - further delineation of the 6q14 microdeletion syndrome and review of the literature.
    Becker K; Di Donato N; Holder-Espinasse M; Andrieux J; Cuisset JM; Vallée L; Plessis G; Jean N; Delobel B; Thuresson AC; Annerén G; Ravn K; Tümer Z; Tinschert S; Schrock E; Jønch AE; Hackmann K
    Eur J Med Genet; 2012; 55(8-9):490-7. PubMed ID: 22561202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A de novo 10p11.23-p12.1 deletion recapitulates the phenotype observed in WAC mutations and strengthens the role of WAC in intellectual disability and behavior disorders.
    Abdelhedi F; El Khattabi L; Essid N; Viot G; Letessier D; Lebbar A; Dupont JM
    Am J Med Genet A; 2016 Jul; 170(7):1912-7. PubMed ID: 27119754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 1 Mb de novo deletion within 11q13.1q13.2 in a boy with mild intellectual disability and minor dysmorphic features.
    Floor K; Barøy T; Misceo D; Kanavin OJ; Fannemel M; Frengen E
    Eur J Med Genet; 2012 Dec; 55(12):695-9. PubMed ID: 22986108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Array-based comparative genome hybridization in clinical genetics.
    Bar-Shira A; Rosner G; Rosner S; Goldstein M; Orr-Urtreger A
    Pediatr Res; 2006 Sep; 60(3):353-8. PubMed ID: 16857771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined deletion 18q22.2 and duplication/triplication 18q22.1 causes microcephaly, mental retardation and leukencephalopathy.
    Nguyen-Minh S; Drossel K; Horn D; Rost I; Spors B; Kaindl AM
    Gene; 2013 Jul; 523(1):92-8. PubMed ID: 23566840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What can we learn from old microdeletion syndromes using array-CGH screening?
    Mosca-Boidron AL; Bouquillon S; Faivre L; Callier P; Andrieux J; Marle N; Bonnet C; Vincent-Delorme C; Berri M; Plessis G; Manouvrier-Hanu S; Dieux-Coeslier A; Thauvin-Robinet C; Pipiras E; Delahaye A; Payet M; Ragon C; Masurel-Paulet A; Questiaux E; Benzacken B; Jonveaux P; Mugneret F; Holder-Espinasse M
    Clin Genet; 2012 Jul; 82(1):41-7. PubMed ID: 21722100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and Brain Imaging Findings Associated With a 10p Proximal Deletion Including the WAC Gene: Case Report and Literature Review.
    Bolat H; Derin H; Ünsel-Bolat G
    Cogn Behav Neurol; 2022 Sep; 35(3):221-226. PubMed ID: 35766809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of 4.4 Mb at 2q33.2q33.3 May Cause Growth Deficiency in a Patient with Mental Retardation, Facial Dysmorphic Features and Speech Delay.
    Papoulidis I; Paspaliaris V; Papageorgiou E; Siomou E; Dagklis T; Sotiriou S; Thomaidis L; Manolakos E
    Cytogenet Genome Res; 2015; 145(1):19-24. PubMed ID: 25925190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes.
    Bruno DL; Anderlid BM; Lindstrand A; van Ravenswaaij-Arts C; Ganesamoorthy D; Lundin J; Martin CL; Douglas J; Nowak C; Adam MP; Kooy RF; Van der Aa N; Reyniers E; Vandeweyer G; Stolte-Dijkstra I; Dijkhuizen T; Yeung A; Delatycki M; Borgström B; Thelin L; Cardoso C; van Bon B; Pfundt R; de Vries BB; Wallin A; Amor DJ; James PA; Slater HR; Schoumans J
    J Med Genet; 2010 May; 47(5):299-311. PubMed ID: 20452996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel de novo 1.8 Mb microdeletion of 17q21.33 associated with intellectual disability and dysmorphic features.
    Preiksaitiene E; Männik K; Dirse V; Utkus A; Ciuladaite Z; Kasnauskiene J; Kurg A; Kučinskas V
    Eur J Med Genet; 2012 Nov; 55(11):656-9. PubMed ID: 22842074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal and postnatal findings in a 10.6 Mb interstitial deletion at 10p11.22-p12.31.
    Sosoi S; Streata I; Tudorache S; Burada F; Siminel M; Cernea N; Ioana M; Iliescu DG; Mixich F
    J Hum Genet; 2015 Apr; 60(4):183-5. PubMed ID: 25652353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardation.
    Battaglia A; Hoyme HE; Dallapiccola B; Zackai E; Hudgins L; McDonald-McGinn D; Bahi-Buisson N; Romano C; Williams CA; Brailey LL; Zuberi SM; Carey JC
    Pediatrics; 2008 Feb; 121(2):404-10. PubMed ID: 18245432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A patient with 9q subtelomeric deletion syndrome with additional findings.
    Tug E; Cavdarli B; Karaoguz MY; Percin FE
    Genet Couns; 2012; 23(4):465-71. PubMed ID: 23431745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a patient with intellectual disability and de novo 3.7 Mb deletion supports the existence of a novel microdeletion syndrome in 2p14-p15.
    Hancarova M; Vejvalkova S; Trkova M; Drabova J; Dleskova A; Vlckova M; Sedlacek Z
    Gene; 2013 Mar; 516(1):158-61. PubMed ID: 23266801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural chromosomal abnormalities in patients with mental retardation and/or multiple congenital anomalies: a new series of 24 patients.
    Tos T; Karaman A; Aksoy A; Tukun A
    Genet Couns; 2012; 23(2):289-96. PubMed ID: 22876589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.